|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Research and development (including $0 and $1,796 from related party, for the year ended December 31, 2025 and December 31, 2024, respectively) | ||
| General and administrative (including $134 and $2,972 from related party, for the years ended December 31, 2025 and December 31, 2024, respectively) | ||
| TOTAL OPERATING EXPENSES | ||
| OPERATING LOSS | ||
| Financial expenses (income), net (including $232 and $(1,249) from related party, for the years ended December 31, 2025 and December 31, 2024, respectively) | ||
| LOSS BEFORE INCOME TAX | ||
| INCOME TAX | ||
| NET LOSS FOR THE YEAR | ||
| LOSS PER ORDINARY SHARE, BASIC | ||
| LOSS PER ORDINARY SHARE, DILUTED | ||
| WEIGHTED AVERAGE NUMBER OF ORDINARY SHARES OUTSTANDING USED IN COMPUTATION OF BASIC LOSS PER SHARE | ||
| WEIGHTED AVERAGE NUMBER OF ORDINARY SHARES OUTSTANDING USED IN COMPUTATION OF DILUTED LOSS PER SHARE | ||
| Attributable to: | ||
| Equity holders of the Company | ||
| Non-controlling interests |
Loading...
